Phoenix Holdings Ltd. Entera Bio Ltd. Transaction History

Phoenix Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$1.16 - $6.9 $14,383 - $85,560	-12,400 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$1.05 - $2.2 $26,250 - $55,000	-25,000 Reduced 66.84%	12,400 $15,000
Q2 2020 Aug 10, 2020	SELL	$1.71 - $3.01 $54,643 - $96,184	-31,955 Reduced 46.07%	37,400 $66,000
Q1 2020 May 20, 2020	BUY	$1.6 - $3.34 $110,968 - $231,645	69,355 New	69,355 $138,000

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $65.1M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.